InsiderClue
Stocks · Health care · Pharmaceutical Preparations

Kura Oncology, Inc.

KURA Clue Score49
United States Fiscal year ends December CIK 0001422143 Results filed 12 Aug 2026
Add to watchlist

What the insiders did Net buying

Individual transactions

14
Insider
Date
Role
Action
Shares
Price
Amount
Troy Edward Wilson
24 Aug 2026
President and CEO
Buy indirect
100,000
$12.39
$1.24M
Troy Edward Wilson
17 Aug 2026
President and CEO
Buy indirect
100,000
$11.12
$1.11M
Troy Edward Wilson
8 Sep 2025
President & CEO
Buy
50,000
$8.20
$410.15K
Troy Edward Wilson
13 Aug 2025
President and CEO
Buy
13,494
$6.64
$89.62K
Troy Edward Wilson
12 Aug 2025
President and CEO
Buy
36,506
$5.85
$213.58K
Thomas Malley
16 Jun 2023
Director
Buy indirect
50,000
$11.50
$575.00K
EcoR1 Capital Fund Qualified, L.P.
21 Dec 2018
10% owner
Buy
83,540
$13.16
$1.10M
EcoR1 Capital Fund Qualified, L.P.
19 Dec 2018
10% owner
Buy
51,879
$13.84
$718.01K
EcoR1 Capital Fund Qualified, L.P.
18 Dec 2018
10% owner
Buy
78,469
$13.82
$1.08M
EcoR1 Capital Fund Qualified, L.P.
13 Dec 2018
10% owner
Buy
25,217
$13.89
$350.26K
EcoR1 Capital Fund Qualified, L.P.
11 Dec 2018
10% owner
Buy
15,321
$13.91
$213.10K
EcoR1 Capital Fund Qualified, L.P.
6 Dec 2018
10% owner
Buy
17,079
$13.49
$230.40K
EcoR1 Capital Fund Qualified, L.P.
4 Dec 2018
10% owner
Buy
54,645
$13.08
$714.76K
EcoR1 Capital Fund Qualified, L.P.
3 Dec 2018
10% owner
Buy
48,182
$13.97
$673.10K
Show all 133 transactions →

What was left out

Form 4 filings counted 220
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 18
Sales straight out of an exercise 31
Sales at will 62
Transactions with no price 0
Shares from compensation/vesting 6,262,237
Sales filed before the plan box existed 11
History held since 10 Mar 2015